Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | ACACB | O00763 | 5/20 | 0.55 |
| ▸ | FPR2 | P25090 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.46 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.46 |
| ▸ | TAS1R2 | Q8TE23 | 2/20 | 0.46 |
| ▸ | BRD4 | O60885 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1816088 | 0.83 | ACACB (0.56) | SMN1; SMN2PKMACACBFPR2RAB9A | |
| SCHEMBL1812464 | 0.82 | CNR1 (0.57) | ACACBFPR2RAB9ANPC1LMNA | |
| SCHEMBL9893002 | 0.78 | ACACB (0.82) | ACACB | |
| SCHEMBL9891904 | 0.76 | ACACB (0.61) | ACACBFPR2RAB9ANPC1SLC6A2 | |
| SCHEMBL12204087 | 0.76 | ACACB (0.57) | ACACBFPR2RAB9ANPC1SLC6A2 | |
| SCHEMBL1815467 | 0.75 | NPC1 (0.54) | SMN1; SMN2PKMRAB9ANPC1TAS1R3 | |
| SCHEMBL1816209 | 0.75 | ACACB (0.53) | ACACBFPR2RAB9ANPC1MEN1 | |
| SCHEMBL12654827 | 0.75 | ACACB (0.50) | SMN1; SMN2ACACBFPR2RAB9ANPC1 | |
| SCHEMBL12621261 | 0.74 | UTS2R (0.54) | PKMACACBFPR2RAB9ANPC1 | |
| SCHEMBL4169995 | 0.74 | PKM (0.70) | SMN1; SMN2PKMTAS1R3TAS1R1TAS1R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8314269-B2 | N-(1-methyl-2phenylethyl)benzamide derivatives | BAYER CROPSCIENCE AG (DE) | 2012-11-20 | — | — | US | claimed |
| US-20110237678-A1 | N-(1-METHYL-2PHENYLETHYL)BENZAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2011-09-29 | — | — | US | claimed |
| US-20090156682-A1 | N-(1-Methyl-2Phenylethyl)Benzamide Derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2009-06-18 | — | — | US | claimed |
| EP-1960350-A1 | NEW N-(1-METHYL-2PHENYLETHYL)BENZAMIDE DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2008-08-27 | — | — | EP | claimed |
| WO-2007060162-A1 | NEW N-(1-METHYL-2PHENYLETHYL)BENZAMIDE DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2007-05-31 | — | — | WO | claimed |
| US-8314269-B2 | N-(1-methyl-2phenylethyl)benzamide derivatives | BAYER CROPSCIENCE AG (DE) | 2012-11-20 | — | — | US | disclosed |
| US-20110237678-A1 | N-(1-METHYL-2PHENYLETHYL)BENZAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2011-09-29 | — | — | US | disclosed |
| US-7951973-B2 | N-(1-methyl-2Phenylethyl)benzamide derivatives | BAYER CROPSCIENCE AG (DE) | 2011-05-31 | — | — | US | disclosed |
| US-20090156682-A1 | N-(1-Methyl-2Phenylethyl)Benzamide Derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2009-06-18 | — | — | US | disclosed |
| EP-1960350-A1 | NEW N-(1-METHYL-2PHENYLETHYL)BENZAMIDE DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2008-08-27 | — | — | EP | disclosed |
| WO-2007060162-A1 | NEW N-(1-METHYL-2PHENYLETHYL)BENZAMIDE DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2007-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156682-A1 | N-(1-Methyl-2Phenylethyl)Benzamide Derivatives | CYP51A1, CYP1A2, CYP1A1 | SMN1; SMN2 1807/4885PKM 690/4885ACACB 2344/4885 |
| US-20110237678-A1 | N-(1-METHYL-2PHENYLETHYL)BENZAMIDE DERIVATIVES | CYP51A1, CYP1A2, CYP1A1 | SMN1; SMN2 1859/4885PKM 662/4885ACACB 2371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.